Immune Pharmaceuticals Inc.’s Acquisition of the rights to Ceplene from Meda A.B.

Pearl Cohen represented Immune Pharmaceuticals Inc. in its transaction to acquire the rights to Ceplene from Meda A.B., now part of Mylan, a global healthcare company….

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now